ADC Therapeutics’ recently approved cancer treatment Zynlonta will be commercially manufactured by Avid Bioservices in Tustin, California.   Contract development manufacturing organization (CDMO) Avid Bioservices will manufacture the monoclonal antibody portion of the antibody-drug conjugate (ADC) Zynlonta (loncastuximab tesirine), which received US Food and Drug Administration (FDA) approval in April. Avid has provided ADC Therapeutics with clinical manufacturing services since 2017. However, the firm will now undertake commercial manufacturing activities for Zynlonta, which is used to treat patients with relapsed or…

Moderna has inked a deal with Samsung Biologics and Novavax has signed a memorandum of understanding with SK bioscience to provide global access to their vaccines. Novavax has not yet received authorization for its recombinant protein COVID-19 vaccine candidate NVX-CoV2373 but it is prepping for commercialization, signing a non-binding memorandum of understanding (MoU) with the Ministry of Health and Welfare of Korea and contract development manufacturing organization (CDMO) SK bioscience. Under the terms of the agreement, SK bioscience will continue…